127 results
Page 4 of 7
424B5
1lsr t23mlqi13vzj0
20 Oct 21
Prospectus supplement for primary offering
4:15pm
8-K
EX-99.1
nde9mce54t77 yf
2 Sep 21
Crinetics Pharmaceuticals Expands Executive Team with Addition of Jeff Knight as Chief Operating Officer
5:00pm
S-3ASR
0yb2 qjcow
10 Aug 21
Automatic shelf registration
5:25pm
S-3ASR
EX-4.4
wusqvss7
10 Aug 21
Automatic shelf registration
5:25pm
8-K
EX-99.1
fs7g isefi
29 Jul 21
Stock Purchase Agreement
4:15pm
8-K
EX-1.1
edkr8r g8fzqnyztsic
8 Apr 21
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4:09pm
424B5
ht9in
8 Apr 21
Prospectus supplement for primary offering
4:07pm
8-K
EX-99.1
rpzl wnun
3 Sep 20
Crinetics Pharmaceuticals Appoints Rare Disease Executive, Camille L. Bedrosian, M.D., to Board of Directors
7:35am